Home |
Free Dividend Report |
Stock Splits Calendar |
AKBA Historical Stock Prices |
Preferred Stock Newsletter |
AKBA Options Chain |
Stock Message Boards |
Akebia Therapeutics (AKBA) has the following price history information. Looking back at AKBA historical stock prices for the last five trading days, on April 19, 2024, AKBA opened at $1.35, traded as high as $1.38 and as low as $1.31, and closed at $1.36. Trading volume was a total of 2.96M shares. On April 22, 2024, AKBA opened at $1.37, traded as high as $1.40 and as low as $1.34, and closed at $1.36. Trading volume was a total of 2.01M shares. On April 23, 2024, AKBA opened at $1.38, traded as high as $1.41 and as low as $1.35, and closed at $1.37. Trading volume was a total of 2.11M shares. On April 24, 2024, AKBA opened at $1.37, traded as high as $1.40 and as low as $1.35, and closed at $1.37. Trading volume was a total of 1.54M shares. On April 25, 2024, AKBA opened at $1.35, traded as high as $1.35 and as low as $1.31, and closed at $1.33. Trading volume was a total of 2.55M shares.
AKBA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akebia Therapeutics shares, starting with a $10,000 purchase of AKBA, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 04/25/2024 | |
Start price/share: | $24.16 | |
End price/share: | $1.33 | |
Dividends collected/share: | $0.00 | |
Total return: | -94.50% | |
Average Annual Total Return: | -25.18% | |
Starting investment: | $10,000.00 | |
Ending investment: | $550.20 | |
Years: | 10.00 |
AKBA Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/19/2024 | $1.35 | $1.38 | $1.31 | $1.36 | 2.96M |
04/22/2024 | $1.37 | $1.40 | $1.34 | $1.36 | 2.01M |
04/23/2024 | $1.38 | $1.41 | $1.35 | $1.37 | 2.11M |
04/24/2024 | $1.37 | $1.40 | $1.35 | $1.37 | 1.54M |
04/25/2024 | $1.35 | $1.35 | $1.31 | $1.33 | 2.55M |
About Akebia Therapeutics |
Akebia Therapeutics is a biopharmaceutical company. Co.'s portfolio includes a late-stage product candidate and a commercial product: Vadadustat, which is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor designed to mimic the physiologic effect of altitude on oxygen availability; and Auryxia® (ferric citrate), which is approved and marketed in the U.S. for two indications which are the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis or the Hyperphosphatemia Indication, and the treatment of iron deficiency anemia (IDA) in adult patients with CKD not on dialysis or the IDA Indication. |
AKBA Historical Closing Prices | |
Date | Close |
04/19/2024 | $1.36 |
04/22/2024 | $1.36 |
04/23/2024 | $1.37 |
04/24/2024 | $1.37 |
04/25/2024 | $1.33 |
Healthcare Historical Prices |
AKBA is categorized under the Healthcare sector; below are some other companies in the same sector:
AKCA Historical Stock Prices Also explore: AKBA shares outstanding history
Free AKBA Email Alerts:
|
AKBA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.